The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy

Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population

(2016) Tian Yang et al.   Cancer Epidemiology

Overexpression of MAC30 is Resistant to Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer

(2016) Ruhua Chen et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

The Prognostic Effect of MAC30 Expression on Patients With Non–Small Cell Lung Cancer Receiving Adjuvant Chemotherapy

(2016) Hui Ding et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation

(2016) Kohei Matsumoto et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

(2014) Y Kurokawa et al.   BRITISH JOURNAL OF CANCER

Down-Regulated MAC30 Expression Inhibits Proliferation and Mobility of Human Gastric Cancer Cells

(2014) Xiao-Yan Xu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

(2013) Chao-Zhu He et al.   BMC GASTROENTEROLOGY

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

(2013) Atsushi Ohtsu et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer

(2012) Min Xiao et al.   JOURNAL OF SURGICAL ONCOLOGY

Overexpression of MAC30 in the Cytoplasm of Oral Squamous Cell Carcinoma Predicts Nodal Metastasis and Poor Differentiation

(2010) Bao-Yong Yan et al.   CHEMOTHERAPY